ARTICLE | Company News

Dr. Reddy's, Oceana sales and marketing update

May 23, 2011 7:00 AM UTC

Oceana granted Dr. Reddy's exclusive Indian commercialization rights for genitourinary compound Deflux. The gel of 50 mg/mL dextranomer microspheres in a carrier gel of non-animal 15 mg/mL stabilized hyaluronic acid (HA) is injected submucosally in the bladder and is approved to treat vesicoureteral reflux (VUR), a malformation of the urinary bladder in children. Further terms were not disclosed...